These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 25699021)

  • 1. Insulin/Insulin-like growth factors in cancer: new roles for the aryl hydrocarbon receptor, tumor resistance mechanisms, and new blocking strategies.
    Salisbury TB; Tomblin JK
    Front Endocrinol (Lausanne); 2015; 6():12. PubMed ID: 25699021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct integrin binding to insulin-like growth factor-2 through the C-domain is required for insulin-like growth factor receptor type 1 (IGF1R) signaling.
    Cedano Prieto DM; Cheng Y; Chang CC; Yu J; Takada YK; Takada Y
    PLoS One; 2017; 12(9):e0184285. PubMed ID: 28873464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of insulin receptor by antibodies against the type I insulin-like growth factor receptor: implications for anti-insulin-like growth factor therapy in breast cancer.
    Sachdev D; Singh R; Fujita-Yamaguchi Y; Yee D
    Cancer Res; 2006 Feb; 66(4):2391-402. PubMed ID: 16489046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LMP1 promotes expression of insulin-like growth factor 1 (IGF1) to selectively activate IGF1 receptor and drive cell proliferation.
    Tworkoski K; Raab-Traub N
    J Virol; 2015 Mar; 89(5):2590-602. PubMed ID: 25520502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human aortic smooth muscle cells are insulin resistant at the receptor level but sensitive to IGF1 and IGF2.
    Chisalita SI; Johansson GS; Liefvendahl E; Bäck K; Arnqvist HJ
    J Mol Endocrinol; 2009 Dec; 43(6):231-9. PubMed ID: 19589910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin.
    Zhang H; Pelzer AM; Kiang DT; Yee D
    Cancer Res; 2007 Jan; 67(1):391-7. PubMed ID: 17210722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Influences Sensitivity to Anti-IGF System Agents Through the Translational Regulation of
    Mancarella C; Pasello M; Manara MC; Toracchio L; Sciandra EF; Picci P; Scotlandi K
    Front Endocrinol (Lausanne); 2018; 9():178. PubMed ID: 29731738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Pathways: Clinical Applications and Future Direction of Insulin-like Growth Factor-1 Receptor Pathway Blockade.
    Iams WT; Lovly CM
    Clin Cancer Res; 2015 Oct; 21(19):4270-7. PubMed ID: 26429980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of disease: signaling of the insulin-like growth factor 1 receptor pathway--therapeutic perspectives in cancer.
    Tao Y; Pinzi V; Bourhis J; Deutsch E
    Nat Clin Pract Oncol; 2007 Oct; 4(10):591-602. PubMed ID: 17898809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1.
    LeRoith D; Yakar S
    Nat Clin Pract Endocrinol Metab; 2007 Mar; 3(3):302-10. PubMed ID: 17315038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The type 1 insulin-like growth factor receptor signalling system and targeted tyrosine kinase inhibition in cancer.
    Haisa M
    J Int Med Res; 2013 Apr; 41(2):253-64. PubMed ID: 23569026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factors in human breast cancer.
    Ellis MJ; Jenkins S; Hanfelt J; Redington ME; Taylor M; Leek R; Siddle K; Harris A
    Breast Cancer Res Treat; 1998; 52(1-3):175-84. PubMed ID: 10066081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly specific role of the insulin receptor in breast cancer progression.
    Rostoker R; Abelson S; Bitton-Worms K; Genkin I; Ben-Shmuel S; Dakwar M; Orr ZS; Caspi A; Tzukerman M; LeRoith D
    Endocr Relat Cancer; 2015 Apr; 22(2):145-57. PubMed ID: 25694511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical evaluation of Insulin-like growth factor receptor 1 (IGF1R) and Insulin Receptor (IR) as a therapeutic targets in triple negative breast cancer.
    Roche S; Gaule P; Winrow D; Mukherjee N; O'Neill F; Conlon NT; Meiller J; Collins DM; Canonici A; Fawsi MI; Estepa-Fernández A; Madden SF; Crown J; O'Donovan N; Eustace AJ
    PLoS One; 2023; 18(3):e0282512. PubMed ID: 36920947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy.
    Tognon CE; Sorensen PH
    Expert Opin Ther Targets; 2012 Jan; 16(1):33-48. PubMed ID: 22239439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal expression of insulin-like growth factor 1 receptor determines intrinsic resistance of cancer cells to a phosphatidylinositol 3-kinase inhibitor ZSTK474.
    Isoyama S; Kajiwara G; Tamaki N; Okamura M; Yoshimi H; Nakamura N; Kawamura K; Nishimura Y; Namatame N; Yamori T; Dan S
    Cancer Sci; 2015 Feb; 106(2):171-8. PubMed ID: 25483727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of insulin and IGF system in pancreatic cancer.
    Trajkovic-Arsic M; Kalideris E; Siveke JT
    J Mol Endocrinol; 2013 Jun; 50(3):R67-74. PubMed ID: 23493758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the mechanism of bias signaling of the insulin-like growth factor 1 receptor: Effects of LL37 and HASF.
    Bareja A; Patel S; Hodgkinson CP; Payne A; Dzau VJ
    Cell Signal; 2018 Jun; 46():113-119. PubMed ID: 29499305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells.
    Schedlich LJ; Yenson VM; Baxter RC
    Mol Cell Endocrinol; 2013 Sep; 377(1-2):56-64. PubMed ID: 23831640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.